Carl Dambkowski: insider trades

Every open market trade Carl Dambkowski has filed with the SEC, when each filing appeared, and how the buys did against the S&P 500 once the filing was public.

Key Facts

  • Carl Dambkowski is listed as Chief Medical Officer at APGE, ORKA.
  • Between 2026-04-03 (3 April 2026) and 2026-08-07 (7 August 2026) Carl Dambkowski filed 0 open market buys worth $0 and 5 open market sales worth $12M.
  • None of Carl Dambkowski's buys has matured 90 days yet, so there is no return to report.
  • Data as of 2026-09-29 (29 September 2026).
Open market buys 0 $0
Open market sales 5 $12M
Avg vs S&P, 90d n/a 0 scored buys
Beat the S&P n/a 90 days after entry

Would copying Carl Dambkowski have paid?

prices as of 2026-09-28

The result. None of Carl Dambkowski's buys has matured 90 days yet, so there is no return to report.

Average return of Carl Dambkowski's open market buys against the S&P 500.
Days after entryScored buysAvg vs S&PBeat S&PEntry monthst statisticReading
30 days 0 n/a n/a n/a n/a too few trades to tell
90 days 0 n/a n/a n/a n/a too few trades to tell
180 days 0 n/a n/a n/a n/a too few trades to tell

A return curve needs at least 10 scored buys. Carl Dambkowski does not have enough yet.

Stocks traded

  1. APGE4 trades, $5.4M
  2. ORKA1 trade, $6.2M

Every open market trade

as of 2026-09-29
5 trades.
Open market trades filed by Carl Dambkowski, newest first.
FiledStockTypeSharesPriceValue90 day vs S&P
7 Aug 2026 APGE sell 5,500 $134.17 $738K n/a
2 Jul 2026 APGE sell 5,500 $132.74 $730K n/a
24 Jun 2026 APGE sell 26,400 $132.60 $3.5M n/a
22 May 2026 ORKA sell 105,000 $58.97 $6.2M n/a
3 Apr 2026 APGE sell 5,500 $84.84 $467K n/a

Insider sales are shown but not scored, because they are often planned for tax or diversification reasons.

Frequently asked questions

What has Carl Dambkowski bought and sold?

Between 2026-04-03 (3 April 2026) and 2026-08-07 (7 August 2026) Carl Dambkowski filed 0 open market buys worth $0 and 5 open market sales worth $12M.

Did Carl Dambkowski's buys beat the market?

None of Carl Dambkowski's buys has matured 90 days yet, so there is no return to report. Insider sales are not scored because they are often planned for tax or diversification reasons.

Sources: Insider trades: SEC Form 4 filings, collected from Finviz. Prices: Yahoo Finance daily adjusted closes. Data as of 2026-09-29 (29 September 2026). About these sources.

Not investment advice. Past disclosed trades do not predict future returns. Disclosures are published late, so the trades shown are ones you could only have copied after the fact. Talk to a licensed adviser before you invest.